ABOUT THE PRODUCT
An advanced cell armoring platform that enhances ACT therapies by equipping them to overcome TME barriers and heterogeneity, improving safety, infiltration, and persistence in solid tumors.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
